tiprankstipranks
Trending News
More News >
BaWang International (Group) Holding Limited (HK:1338)
:1338
Hong Kong Market

BaWang International (Group) Holding Limited (1338) AI Stock Analysis

Compare
0 Followers

Top Page

HK

BaWang International (Group) Holding Limited

(1338)

Rating:63Neutral
Price Target:
HK$0.00
▼(-100.00%Downside)
The overall stock score is influenced primarily by solid financial performance, particularly revenue growth and cost management. However, technical indicators suggest limited momentum, and valuation metrics show moderate pricing without dividend support. Addressing cash flow and liquidity issues remains critical for improving financial stability.

BaWang International (Group) Holding Limited (1338) vs. iShares MSCI Hong Kong ETF (EWH)

BaWang International (Group) Holding Limited Business Overview & Revenue Model

Company DescriptionBaWang International (Group) Holding Limited, together with its subsidiaries, designs, manufactures, trades in, and distributes Chinese herbal products in the People's Republic of China, Hong Kong, Thailand, and Malaysia. It operates through Hair-Care Products, Skin-Care Products, and Other Household and Personal Care Products segments. The company offers shampoo, hair-care, skin-care, household cleaning, and shower gel products, as well as laundry detergents and anti-bacterial hand gel under the Bawang, Royal Wind, Herborn, and Litao brands through distributors and retailers; and through online. It also manufactures, markets, and trades in household and personal care products. The company was incorporated in 2007 and is based in Guangzhou, the People's Republic of China. BaWang International (Group) Holding Limited is a subsidiary of Fortune Station Limited.
How the Company Makes MoneyBaWang International generates revenue primarily through the sale of its herbal personal care products, including shampoos and hair care solutions, in both domestic and international markets. The company employs a multi-channel sales strategy, distributing products via retail outlets, e-commerce platforms, and direct sales channels. Additionally, BaWang capitalizes on strategic marketing partnerships and brand endorsements to enhance its market presence and consumer reach. The company's earnings are influenced by its ability to innovate product offerings, maintain effective distribution networks, and uphold brand reputation in the competitive personal care industry.

BaWang International (Group) Holding Limited Financial Statement Overview

Summary
BaWang International has demonstrated revenue growth and efficient cost management, contributing to a solid gross profit margin. The balance sheet is strong with low leverage, but challenges remain in maintaining asset levels and generating cash flow. Addressing liquidity issues could enhance overall financial stability.
Income Statement
72
Positive
The company has shown steady revenue growth with a recent 6.43% increase in 2024. The gross profit margin improved to 50.91%, indicating efficient cost management. However, the net profit margin declined slightly to 2.59%, and EBIT margin decreased to 3.00%, suggesting challenges in controlling operating expenses.
Balance Sheet
78
Positive
The balance sheet reflects a solid equity position with an equity ratio of 61.79%. The debt-to-equity ratio is low at 0.11, indicating conservative leverage. However, a decline in total assets over recent years could pose future challenges.
Cash Flow
65
Positive
The company reported zero free cash flow in 2024, indicating potential cash management issues. Previously, it had positive free cash flow growth and a healthy operating cash flow to net income ratio. The lack of operating cash flow in 2024 suggests liquidity concerns.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue252.95M237.65M246.34M273.60M275.99M
Gross Profit128.78M119.72M92.52M99.03M108.10M
EBITDA14.25M31.50M15.19M25.01M26.93M
Net Income6.55M13.63M-19.43M-9.08M-4.04M
Balance Sheet
Total Assets235.43M230.33M244.23M295.58M264.57M
Cash, Cash Equivalents and Short-Term Investments120.32M88.27M74.40M63.27M122.34M
Total Debt15.89M25.10M33.28M53.45M11.48M
Total Liabilities89.97M90.83M118.21M149.72M109.84M
Stockholders Equity145.47M139.50M126.02M145.85M154.73M
Cash Flow
Free Cash Flow12.19M1.78M22.15M-65.00K34.92M
Operating Cash Flow31.15M4.05M24.11M1.60M37.89M
Investing Cash Flow11.67M19.35M-177.00K-50.52M-1.18M
Financing Cash Flow-10.16M-9.07M-11.28M-11.44M-16.81M

BaWang International (Group) Holding Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.05
Price Trends
50DMA
0.05
Negative
100DMA
0.05
Positive
200DMA
0.05
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
48.94
Neutral
STOCH
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1338, the sentiment is Positive. The current price of 0.05 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and above the 200-day MA of 0.05, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.94 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1338.

BaWang International (Group) Holding Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$27.34B15.36-4.01%3.14%1.00%1.98%
63
Neutral
HK$154.96M22.274.61%4.77%-53.19%
$140.29M-20.26%
63
Neutral
HK$308.38M7.944.83%11.55%3.79%-18.75%
60
Neutral
HK$696.65M10.868.96%30.72%-35.61%
44
Neutral
HK$70.00M21.881.13%5.97%-12.00%-57.89%
40
Underperform
HK$180.15M-27.11%-6.77%-26.30%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1338
BaWang International (Group) Holding Limited
0.05
0.00
0.00%
NBBTF
Natural Beauty Bio-Technology
0.05
0.01
25.00%
HK:1962
Evergreen Products Group Ltd.
0.48
0.08
20.00%
HK:3332
Nanjing Sinolife United Co., Ltd. Class H
0.43
-0.32
-42.67%
HK:6893
Hin Sang Group (International) Holding Co. Ltd.
0.16
-0.12
-42.86%
HK:8281
China Golden Classic Group Ltd.
0.07
-0.06
-46.15%

BaWang International (Group) Holding Limited Corporate Events

BaWang International Successfully Passes All Resolutions at AGM
May 30, 2025

BaWang International (Group) Holding Limited announced that all ordinary resolutions were passed at their Annual General Meeting held on May 30, 2025. The resolutions included the re-election of directors, approval of financial statements, and granting of mandates for share issuance and repurchase. This successful meeting indicates strong shareholder support and could enhance the company’s governance and operational strategies moving forward.

BaWang International Issues Clarification on Share Mandates and Director Re-election
Apr 28, 2025

BaWang International (Group) Holding Limited has issued a clarification announcement regarding its general mandates to issue and repurchase shares, as well as the re-election of directors and notice of its annual general meeting. The company confirms that there are no unusual features in the explanatory statement or the proposed repurchase of shares, and no changes have been made to the information contained in the previously issued circular.

BaWang International Announces 2025 Annual General Meeting
Apr 28, 2025

BaWang International (Group) Holding Limited has announced its annual general meeting to be held on May 30, 2025, in Guangzhou, China. Key agenda items include the consideration of audited financial statements, re-election of directors, re-appointment of auditors, and authorization for the board to manage share allotments. These decisions are pivotal for the company’s governance and strategic planning, potentially impacting its operational efficiency and shareholder value.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 24, 2025